| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |